Autism spectrum disorders and symptoms in children with molecularly confirmed 22q11.2 deletion syndrome
- PMID: 16134031
- PMCID: PMC2814423
- DOI: 10.1007/s10803-005-5036-9
Autism spectrum disorders and symptoms in children with molecularly confirmed 22q11.2 deletion syndrome
Abstract
In this study, we assessed the presence of autism spectrum disorders (ASD) among children with a confirmed 22q11.2 deletion (n = 98). The children's caregivers completed screening measures of ASD behaviors, and for those whose scores indicated significant levels of these behaviors, a standardized diagnostic interview (Autism Diagnostic Interview-Revised; ADI-R) was administered. Results demonstrated that over 20% of children (n = 22) were exhibiting significant levels of autism spectrum symptoms based on the screening measures. Based upon the ADI-R, 14 children qualified for a diagnosis of an ASD, and for 11 of those children a diagnosis of autism was most appropriate. These findings increase our knowledge of developmental disorders associated with the 22q11.2 deletion and point to avenues for future investigation.
References
-
- American Psychiatric Association . Diagnostic and statistical manual of mental disorders. 4th ed Author; Washington, DC: 1994.
-
- Arnold PD, Siegel-Bartelt J, Cytrynbaum C, Teshima I, Schachar R. Velo-cardio-facial syndrome: Implications of microdeletion 22q11 for schizophrenia and mood disorders. American Journal of Medical Genetics. 2001;105:354–362. - PubMed
-
- Berument SK, Rutter M, Lord C, Pickles A, Bailey A. Autism screening questionnaire: Diagnostic validity. British Journal of Psychiatry. 1999;175:444–451. - PubMed
-
- Bolton P, Macdonald H, Pickles A, Rios P, Goode S, Crowson M. A case-control family history study of autism. Journal of Child Psychology and Psychiatry. 1994;35:877–900. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
